6-Bromo-4(3H)-quinazolinone
98%
- Product Code: 85562
CAS:
32084-59-6
| Molecular Weight: | 225.05 g./mol | Molecular Formula: | C₈H₅BrN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00115131 | |
| Melting Point: | Boiling Point: | 374.2℃ | |
| Density: | 1.82g/cm3 | Storage Condition: | 2-8 °C, dry |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antitumor and anticancer agents. Its structure is valuable in creating quinazoline derivatives, which are studied for their potential to inhibit enzymes like tyrosine kinases, crucial in cancer cell proliferation. Also employed in organic research for designing novel bioactive molecules with therapeutic applications.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white to brown or gray solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿600.00 |
+
-
|
| 5.000 | 10-20 days | ฿2,280.00 |
+
-
|
| 25.000 | 10-20 days | ฿9,870.00 |
+
-
|
6-Bromo-4(3H)-quinazolinone
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antitumor and anticancer agents. Its structure is valuable in creating quinazoline derivatives, which are studied for their potential to inhibit enzymes like tyrosine kinases, crucial in cancer cell proliferation. Also employed in organic research for designing novel bioactive molecules with therapeutic applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :